Stupp, Roger ; Mason, Warren P. ; van den Bent, Martin J. ; Weller, Michael ; Fisher, Barbara ; Taphoorn, Martin J. B. ; Belanger, Karl ; Brandes, Alba A. ; Marosi, Christine ; Bogdahn, Ulrich ; Curschmann, Jürgen ; Janzer, Robert C. ; Ludwin, Samuel K. ; Gorlia, Thierry ; Allgeier, Anouk ; Lacombe, Denis ; Cairncross, J. Gregory ; Eisenhauer, Elizabeth ; Mirimanoff, René O.
| Item type: | Article | ||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Journal or Publication Title: | The New England journal of medicine | ||||||||||||||||||||||||||||||||||
| Publisher: | Massachusetts Medical Society | ||||||||||||||||||||||||||||||||||
| Volume: | 352 | ||||||||||||||||||||||||||||||||||
| Number of Issue or Book Chapter: | 10 | ||||||||||||||||||||||||||||||||||
| Page Range: | pp. 987-996 | ||||||||||||||||||||||||||||||||||
| Date: | 2005 | ||||||||||||||||||||||||||||||||||
| Additional Information (public): | European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group | ||||||||||||||||||||||||||||||||||
| Institutions: | Medicine > Zentren des Universitätsklinikums Regensburg > Zentrum für Hirntumore (ZHT) | ||||||||||||||||||||||||||||||||||
| Identification Number: |
| ||||||||||||||||||||||||||||||||||
| Classification: |
| ||||||||||||||||||||||||||||||||||
| Dewey Decimal Classification: | 600 Technology > 610 Medical sciences Medicine | ||||||||||||||||||||||||||||||||||
| Status: | Published | ||||||||||||||||||||||||||||||||||
| Refereed: | Yes, this version has been refereed | ||||||||||||||||||||||||||||||||||
| Created at the University of Regensburg: | Unknown | ||||||||||||||||||||||||||||||||||
| Item ID: | 29339 |
Abstract
The addition of temozolomide to radiotherapy for newly diagnosed glioblastoma resulted in a clinically meaningful and statistically significant survival benefit with minimal additional toxicity.
Metadata last modified: 29 Sep 2021 07:39
Owner only: item control page
Altmetric
Altmetric